Doxorubicin plus dacarbazine (DoDa), doxorubicin plus ifosfamide (DI) or doxorubicin alone (Do) as first line treatment for advanced leiomyosarcoma (LMS): A retrospective study from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG).

Author:

D'Ambrosio Lorenzo1,Touati Nathan2,Blay Jean-Yves3,Grignani Giovanni4,Flippot Ronan5,Czarnecka Anna Malgorzata6,Piperno-Neumann Sophie7,Martin Broto Javier8,Sanfilippo Roberta9,Katz Daniela10,Duffaud Florence11,Vincenzi Bruno12,Kasper Bernd13,Stark Daniel P.14,Mazzeo Filomena15,Tuchscherer Armin16,Litiere Saskia2,Sents Ward2,Gelderblom Hans17,Gronchi Alessandro18,

Affiliation:

1. University of Torino, Department of Oncology, Torino, Italy, Torino, Italy;

2. European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium;

3. University Claude Bernard Lyon I, Centre Leon Berard, Lyon, France;

4. Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy;

5. Gustave Roussy Cancer Center, Villejuif, France;

6. Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland;

7. Medical Oncology Department, Institut Curie, Paris, France;

8. Virgen del Rocio University Hospital, Institute of Biomedicine Research (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain;

9. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;

10. Oncology Institute, Assaf Harofeh Medical Center, Zrifin, Israel;

11. Service d'Oncologie Médicale Chu la Timone, Marseille, France;

12. Department of Medical Oncology, University Campus Bio-Medico of Rome, Rome, Italy;

13. University of Heidelberg, Mannheim University Medical Center, ITM - Interdisciplinary Tumor Center Mannheim, Sarcoma Unit, Mannheim, Germany;

14. St James's Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals NHS Trust, Bexley Wing, St James's Hospital, Leeds, United Kingdom;

15. Medical Oncology, Clinique Universitaire Saint-Luc, Institut Roi Albert II, Brussels, Belgium;

16. Department I of Internal Medicine, University Hospital Cologne, Köln, Germany;

17. Leiden University Medical Center, Leiden, Netherlands;

18. Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3